Quick Answer
aTYR PHARMA INC reported Cash And Cash Equivalents At Carrying Value of $10.74 million for the year ending 2025.
- aTYR PHARMA INC showed a decrease of -2.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from aTYR PHARMA INC's annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), aTYR PHARMA INC's Cash And Cash Equivalents At Carrying Value has grown by 192.3%.
- Historical annual values: Fiscal year 2025: $10.74 million | Fiscal year 2024: $11.06 million | Fiscal year 2023: $22.54 million | Fiscal year 2022: $9.98 million | Fiscal year 2021: $2.34 million | Fiscal year 2020: $16.95 million | Fiscal year 2019: $9.21 million | Fiscal year 2018: $22.96 million | Fiscal year 2017: $21.09 million | Fiscal year 2016: $38.39 million | Fiscal year 2015: $53.03 million | Fiscal year 2014: $13.90 million | Fiscal year 2013: $36.46 million | Fiscal year 2012: $3.68 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: